Our Pharmacovigilance experts actively track evolving global regulations—so you don’t have to.
To help simplify pharmacovigilance, we stay ahead of new regulations, assess their impact on current practices, and recommend actions that empower professionals to update their MAH systems, processes, and procedures to ensure consistent compliance and drug safety.
This week, we examine the latest regulatory updates in Saudi Arabia and what they mean for your organization.
Author
Dr. Vivek Ahuja serves as EVERSANA’s Executive Vice President of Compliance Services with over 22 years of experience across multiple functional offerings including Pharmacovigilance, Clinical Research, Technology, and Public Health. A physician by education…